SCHEMBL17547850

SCHEMBL17547850

CC(C)c1c(-c2cccc(CNS(C)(=O)=O)c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 2/20 0.42
▸ AURKB Q96GD4 2/20 0.42
▸ BRD4 O60885 2/20 0.41
▸ KDM5A P29375 7/20 0.36
▸ KDM5B Q9UGL1 3/20 0.36
▸ LIPG Q9Y5X9 1/20 0.35
▸ AAK1 Q2M2I8 1/20 0.35
▸ CREBBP Q92793 1/20 0.35
▸ KDM6B O15054 1/20 0.34
▸ KDM5C P41229 1/20 0.34
▸ KDM5D Q9BY66 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34
▸ PHF8 Q9UPP1 1/20 0.34
▸ KDM4D Q6B0I6 1/20 0.34
▸ CSNK1D P48730 1/20 0.33
▸ CSNK1E P49674 1/20 0.33
▸ TLR9 Q9NR96 1/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ CSNK2A2 P19784 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092258 0.87 KDM5B (0.46) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092443 0.85 CSNK2A2 (0.42) BRD4CSNK2A2
SCHEMBL16092274 0.85 KDM5A (0.46) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL17547835 0.84 FASN (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092449 0.84 CSNK2A2 (0.41) BRD4CSNK2A2
SCHEMBL16092428 0.84 KDM5A (0.38) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092447 0.83 PIP4K2A (0.40) BRD4KDM5AKDM5BKDM6BKDM5C
SCHEMBL17547820 0.83 KDM5A (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092438 0.83 BRD4 (0.38) BRD4KDM5AKDM5BKDM6BKDM5C
SCHEMBL16092293 0.82 KDM5A (0.39) KDM5AKDM5BKDM6BKDM5CKDM5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B AURKA 2165/4885AURKB 1671/4885BRD4 71/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B AURKA 2165/4885AURKB 1671/4885BRD4 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback